Piper Sandler Upgrades Zimmer Biomet (ZBH) to Overweight citing 'beatable revenue guidance for the year'
Tweet Send to a Friend
(Updated - March 10, 2023 3:39 AM EST)
Piper Sandler analyst Matthew O'Brien upgraded Zimmer Biomet (NYSE: ZBH) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Matthew O'Brien upgraded Zimmer Biomet (NYSE: ZBH) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
